Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study.

Anthony Martinez,Wei-Han Cheng,Steven E Marx,Shivaji Manthena,Douglas E Dylla, Lauren Wilson,Emmanuel Thomas

Advances in therapy（2023）

引用 0|浏览1

暂无评分

摘要

Patients prescribed 8- vs 12-week DAA therapy had significantly greater prescription refill persistence. Most nonpersistence was due to missed second refills, highlighting the potential benefit of shorter treatment durations in this population.

查看译文

关键词

Compliance, Persistency, Hepatitis C virus, PWID, Real-world study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要